Hysteroscopic Assessment of Fallopian Tubal Patency
1 other identifier
interventional
621
1 country
1
Brief Summary
Disease of the fallopian tubes is one of the most common reasons for infertility. The most common test, a hysterosalpingogram, tends to be painful,inconvenient, and frequently misses concurrent uterine disease. We propose using a less painful technique (through modified office hysteroscopy) for tubal assessment that can be performed in the office rather than hospital radiology and that uses gold standard technology for identifying coexisting uterine conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 3, 2013
CompletedFirst Posted
Study publicly available on registry
December 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2017
CompletedNovember 8, 2017
November 1, 2017
3.9 years
December 3, 2013
November 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hysteroscopic assessment of tubal patency
Patients undergoing the procedure will be informed based on the findings as to whether or not it is believed that their Fallopian tubes are patent
2 years
Study Arms (1)
Salpingography
EXPERIMENTALInfusion of air bubbles through Fallopian tubes with hysteroscopic visualization; typically 1-2 mL is infused. This is less than that typically used in the established technique of sonosalpingography.
Interventions
Infusion of typically 1-2 mL of air bubbles in to the uterine cavity to assess whether they disappear through the ostia in to the Fallopian tubes.
Eligibility Criteria
You may qualify if:
- years old
- Able to give consent
- Must have a uterus
- Must have documented negative testing for gonorrhea and chlamydia within the past year or previously negative when tested with a current partner in a monogamous relationship
- Negative test prior to procedure
You may not qualify if:
- Pregnancy
- Active lower and upper genital tract infection
- Patients with allergies to hysterosalpingogram contrast will not be exposed to a contrast material to which they are allergic
- Premenarchal or postmenopausal
- Unable to read English at a 6th grade level or above
- History of endometrial Ablation
- Asherman's syndrome \> Stage 1
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
Related Publications (1)
Parry JP, Riche D, Rushing J, Linton B, Butler V, Lindheim SR. Performing the Parryscope technique gently for office tubal patency assessment. Fertil Steril. 2017 Oct;108(4):718. doi: 10.1016/j.fertnstert.2017.07.1159. Epub 2017 Aug 31.
PMID: 28843382DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John P. Parry, MD
University of Mississippi Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 3, 2013
First Posted
December 9, 2013
Study Start
December 1, 2013
Primary Completion
October 16, 2017
Study Completion
November 6, 2017
Last Updated
November 8, 2017
Record last verified: 2017-11